Trial Profile
Proof-of-concept trial of neceprevir in combination with ACH 3102 in patients with genotype 1b hepatitis C
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2013
Price :
$35
*
At a glance
- Drugs Deldeprevir (Primary) ; Odalasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 04 Oct 2013 New trial record